Lee's Pharmaceutical Holdings Ltd. | Mutual Funds
Mutual Funds that own Lee's Pharmaceutical Holdings Ltd.
Fidelity Series Intrinsic Opportunities Fund
9,000,000
1.52%
0
0.06%
04/30/2018
Schroder ISF - Asian Smaller Companies
6,690,500
1.12%
239,500
1.75%
12/29/2017
Fidelity Low Priced Stock Fund
5,971,000
1.01%
-2,029,598
0.02%
04/30/2018
SEB SICAV 2 - Asia Small Caps (ex-Japan) Fund
4,679,500
0.79%
1,023,500
1.78%
12/31/2017
Fidelity Funds SICAV - China Consumer
4,059,467
0.69%
1,607,110
0.14%
05/31/2018
DNB Fund - Asian Small Cap
3,730,940
0.63%
0
1.69%
07/31/2018
Vanguard Total International Stock Index Fund
3,538,188
0.6%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
3,003,000
0.51%
0
0.01%
09/05/2018
2,276,954
0.39%
2,276,954
1.55%
03/31/2018
Government Pension Fund - Global (The)
2,140,504
0.36%
1,240,500
0%
12/31/2017
| Address |
1/F, Building 20 East
Hong Kong
Hong Kong
|
|
Employees
|
- |
| Website |
http://www.leespharm.com |
| Updated |
07/08/2019 |
| Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. It operates through the Proprietary Products and Licensed-in Products segments. The Proprietary Products segment involves in manufacturing and selling self-development pharmaceutical products. |
